Lantern Pharma

$18.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.52 (-2.75%) As of 5:05 PM UTC today

Why Robinhood?

You can buy or sell Lantern Pharma and other stocks, options, and ETFs commission-free!

About LTRN

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-11, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX. The listed name for LTRN is Lantern Pharma Inc. Common Stock.

CEO
Panna L. Sharma
Employees
—
Headquarters
Dallas, Texas
Founded
2013
Market Cap
186.49M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
201.17K
High Today
$19.62
Low Today
$18.30
Open Price
$19.14
Volume
31.82K
52 Week High
$24.84
52 Week Low
$10.40

LTRN Earnings

-$0.33
-$0.22
-$0.11
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4

You May Also Like

CTRM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure